Collection: Foundayo

Foundayo (orforglipron) is Eli Lilly's oral, once-daily, non-peptide GLP-1 receptor agonist, supplied as film-coated tablets. All presentations are Prescription Only Medicines.

Healthxchange supplies the Foundayo tablet range to verified registered prescribers across the UK and Ireland. Every order is dispensed against a valid prescription.

Foundayo
  • 25+

    Years in aesthetics

  • 13,000+

    Clinics supplied

  • 98.4%

    Orders Delivered On Time

  • 9×

    Distributor of the Year

Foundayo Product Range

Foundayo is supplied as a once-daily film-coated tablet taken orally, with or without food. Tablets are swallowed whole and must not be broken, crushed or chewed. Dose escalation, titration and patient monitoring follow the manufacturer's Summary of Product Characteristics and the prescriber's own clinical protocol. No purchase can be dispensed without a valid prescription from a UK-registered prescriber. Standard identity and prescribing verification applies to every order.

Pricing shown after login

  • Foundayo Tablets 5.5mg (30) (POM) ▼

    Foundayo▼ (orforglipron) film-coated tablets

    Pharmacology: Oral small-molecule (non-peptide) GLP-1 receptor agonist.

    Licensed indications:

    • Weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, with initial BMI ≥30 kg/m², or ≥27 to <30 kg/m² with at least one weight-related comorbidity

    Administration: Oral, once daily at any time, with no food or water restrictions. Swallow whole. Missed dose: take as soon as possible, never more than one tablet a day. No adjustment for age, renal impairment or mild-to-moderate hepatic impairment. Not recommended in severe hepatic impairment or under 18s.

    Report adverse reactions via the MHRA Yellow Card scheme.

    Login to buy
  • Foundayo Tablets 9mg (30) (POM) ▼

    Foundayo▼ (orforglipron) film-coated tablets

    Pharmacology: Oral small-molecule (non-peptide) GLP-1 receptor agonist.

    Licensed indications:

    • Weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, with initial BMI ≥30 kg/m², or ≥27 to <30 kg/m² with at least one weight-related comorbidity

    Administration: Oral, once daily at any time, with no food or water restrictions. Swallow whole. Missed dose: take as soon as possible, never more than one tablet a day. No adjustment for age, renal impairment or mild-to-moderate hepatic impairment. Not recommended in severe hepatic impairment or under 18s.

    Report adverse reactions via the MHRA Yellow Card scheme.

    Login to buy
  • Foundayo Tablets 2.5mg (30) (POM) ▼

    Foundayo▼ (orforglipron) film-coated tablets

    Pharmacology: Oral small-molecule (non-peptide) GLP-1 receptor agonist.

    Licensed indications:

    • Weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, with initial BMI ≥30 kg/m², or ≥27 to <30 kg/m² with at least one weight-related comorbidity

    Administration: Oral, once daily at any time, with no food or water restrictions. Swallow whole. Missed dose: take as soon as possible, never more than one tablet a day. No adjustment for age, renal impairment or mild-to-moderate hepatic impairment. Not recommended in severe hepatic impairment or under 18s.

    Report adverse reactions via the MHRA Yellow Card scheme.

    Login to buy
  • Foundayo Tablets 17.2mg (30) (POM) ▼

    Foundayo▼ (orforglipron) film-coated tablets

    Pharmacology: Oral small-molecule (non-peptide) GLP-1 receptor agonist.

    Licensed indications:

    • Weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, with initial BMI ≥30 kg/m², or ≥27 to <30 kg/m² with at least one weight-related comorbidity

    Administration: Oral, once daily at any time, with no food or water restrictions. Swallow whole. Missed dose: take as soon as possible, never more than one tablet a day. No adjustment for age, renal impairment or mild-to-moderate hepatic impairment. Not recommended in severe hepatic impairment or under 18s.

    Report adverse reactions via the MHRA Yellow Card scheme.

    Login to buy
  • Foundayo Tablets 14.5mg (30) (POM) ▼

    Foundayo▼ (orforglipron) film-coated tablets

    Pharmacology: Oral small-molecule (non-peptide) GLP-1 receptor agonist.

    Licensed indications:

    • Weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, with initial BMI ≥30 kg/m², or ≥27 to <30 kg/m² with at least one weight-related comorbidity

    Administration: Oral, once daily at any time, with no food or water restrictions. Swallow whole. Missed dose: take as soon as possible, never more than one tablet a day. No adjustment for age, renal impairment or mild-to-moderate hepatic impairment. Not recommended in severe hepatic impairment or under 18s.

    Report adverse reactions via the MHRA Yellow Card scheme.

    Login to buy
  • Foundayo Tablets 0.8mg (30) (POM) ▼

    Foundayo▼ (orforglipron) film-coated tablets

    Pharmacology: Oral small-molecule (non-peptide) GLP-1 receptor agonist.

    Licensed indications:

    • Weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, with initial BMI ≥30 kg/m², or ≥27 to <30 kg/m² with at least one weight-related comorbidity

    Administration: Oral, once daily at any time, with no food or water restrictions. Swallow whole. Missed dose: take as soon as possible, never more than one tablet a day. No adjustment for age, renal impairment or mild-to-moderate hepatic impairment. Not recommended in severe hepatic impairment or under 18s.

    Report adverse reactions via the MHRA Yellow Card scheme.

    Login to buy

Order Foundayo online with Healthxchange

  • 01

    Authenticity & Traceability

    We source directly from premium suppliers to ensure authenticity, traceability and clinical efficacy.

  • 02

    The Trusted partner

    A long-standing partner to over 13,000+ clinics across the UK & Ireland

  • 03

    Next-day delivery

    Consistently delivered on time and in full, so you can plan your stock with confidence.

  • 04

    Training Available

    Access CPD-accredited training on brand and technique, delivered through Healthxchange Academy.

  • 05

    Verified professionals only

    Supplied exclusively to verified healthcare professionals upholding the patient-safety standards our industry depends on.

1 of 5

Frequently asked questions

Clinical and supply questions, answered for practitioners.

What is required to order Foundayo?

A valid prescription from a UK-registered prescriber for each order, in addition to the standard account verification applied to every trade customer.

Who can open a prescriber account?

Registered prescribers only. Accounts require proof of professional registration and prescribing status.

Where do I find prescribing information?

Dosing, titration, contraindications and monitoring are set out in the manufacturer's Summary of Product Characteristics. Product material is available to account holders through the Marketing Portal.

What dose strengths are available?

Foundayo is supplied across the titration range as film-coated tablets from 0.8 mg through to 17.2 mg. Each strength is a separate tablet. Taking more than one tablet per day to reach a higher dose is not recommended by the manufacturer.

How is Foundayo stored and shipped?

Foundayo does not require cold-chain shipping. The manufacturer states that tablets should be stored in the original package in order to protect from light.

Can this page be shared with patients?

No. This page is not indexed and is intended for verified prescriber use only. Patient-facing content must not include brand names, dosing or purchase information.

Buy Foundayo Online with Healthxchange

New accounts approved in under 2 hours* including Marketing Portal access. 

Order the full range in e-Pharmacy, book Academy training, or speak to your Business Development Manager.